David Zacks is an Ophthalmology physician affiliated with University of Michigan. OpenAlex indexes 5 publications with 2,639 citations (h-index 2); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 Wall Street
Ann Arbor, MI 481051912
Telephone
734-764-4190Registry record last updated 21 Oct 2019.
Clinical trials
- Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Research LLCProgram year20251 payment$175,000openpaymentsdata.cms.gov ↗
- EyePoint Pharmaceuticals US, Inc.Program year20241 payment
- Alcon Vision LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
67.7%Corticosteroid25.3%Prednisolone Acetate100%Part D≥12 patientsAminoglycoside Antibacterial25.3%Neomycin-Polymyxin-Dexameth100%Part D≥25 patients+ 1 more class in this area
Musculoskeletal
32.3%Cyclooxygenase Inhibitor32.3%Ketorolac Tromethamine100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- Michigan Vision Clinician Scientist Development Program
University of Michigan at Ann Arbor
FY2026$534,892K12EY022299 - Michigan Vision Clinician Scientist Development Program
University of Michigan at Ann Arbor
FY2025$534,892K12EY022299 - Michigan Vision Clinician Scientist Development Program
University of Michigan at Ann Arbor
FY2024$534,892K12EY022299
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ER Stress and Mitochondrial Perturbations Regulate Cell Death in Retinal Detachment: Exploring the Role of HIF1α
Investigative Ophthalmology & Visual Science
2024 - Pulmonary Tuberculosis in the Second Decade of Life1
American Review of Tuberculosis
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”